Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.550
-0.020 (-1.27%)
At close: Jan 30, 2026, 4:00 PM EST
1.550
0.00 (0.00%)
After-hours: Jan 30, 2026, 4:00 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $9.63 million as of January 30, 2026. Its market cap has decreased by -73.11% in one year.
Market Cap
9.63M
Enterprise Value
-392.47K
1-Year Change
-73.11%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $9.63M, a decrease of -98.47%. That is a compound annual growth rate of -57.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 9.66M | -4.85% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 10.60M |
| Edesa Biotech | 10.25M |
| BioRestorative Therapies | 10.12M |
| CytoMed Therapeutics | 9.71M |
| TransCode Therapeutics | 9.61M |
| GridAI Technologies | 9.58M |
| Pulmatrix | 9.57M |
| Ernexa Therapeutics | 9.42M |